PRKACA
PRKACA (protein kinase cAMP-activated catalytic subunit alpha, also known as PKACa) encodes one of the catalytic subunits of protein kinase A. This serine/threonine kinase carries out cAMP-dependent phosphorylation of target proteins in many cellular processes. Browse Assay Genie's current range of PRKACA research reagents below, or read on for the biology behind the target.
PRKACA is a catalytic subunit of protein kinase A (PKA). In its inactive form, PKA exists as a tetrameric holoenzyme containing two regulatory subunits and two catalytic subunits. When cAMP binds, the holoenzyme dissociates into a dimer of regulatory subunits bound to four cAMP molecules and two free, monomeric catalytic subunits, which are then able to phosphorylate their substrates. In sperm, UniProt annotates PRKACA as phosphorylating and activating ABL1 in the flagellum to promote spermatozoa capacitation.
The enzyme belongs to the protein kinase superfamily, AGC Ser/Thr protein kinase family, cAMP subfamily, and is classified by HGNC within the protein kinase A subunits and protein kinase A family groups. Four regulatory subunits and three catalytic subunits have been identified in humans. UniProt records the protein in the cytoplasm, cell membrane, nucleus, mitochondrion, cilium or flagellum and the acrosome of secretory vesicles. cAMP-dependent phosphorylation by protein kinase A is important in differentiation, proliferation and apoptosis.
The PRKACA gene undergoes alternative splicing, giving multiple transcript variants and different isoforms. Tissue-specific isoforms differ at the N-terminus, and these may differ in the post-translational modifications that occur there. Constitutive activation of the gene, through somatic mutations or genomic duplications of regions that include it, has been associated with hyperplasias and adenomas of the adrenal cortex and linked to corticotropin-independent Cushing's syndrome. Mouse and rat orthologs are both named Prkaca.
PRKACA is a catalytic subunit released when cAMP dissociates the PKA holoenzyme, making it central to studies of cAMP-dependent phosphorylation.
Constitutive activation of PRKACA by somatic mutation or genomic duplication is linked to adrenal cortex hyperplasias and adenomas and corticotropin-independent Cushing's syndrome.
PKA-mediated phosphorylation contributes to differentiation, proliferation and apoptosis, so PRKACA is relevant to work on how cells regulate these processes.
PRKACA phosphorylates and activates ABL1 in the sperm flagellum to promote spermatozoa capacitation, relevant to reproductive biology.
PRKACA encodes a catalytic subunit of protein kinase A. Once cAMP triggers its release from the regulatory subunits, it phosphorylates target proteins involved in differentiation, proliferation and apoptosis. In sperm flagella it phosphorylates and activates ABL1 to promote capacitation.
PRKACA is also called PKACa. Earlier names include protein kinase, cAMP-dependent, catalytic, alpha. Alternative splicing produces multiple transcript variants, and tissue-specific isoforms that differ at the N-terminus have been described, which may differ in N-terminal post-translational modifications.
Constitutive activation of PRKACA, through somatic mutations or genomic duplications, is associated with adrenal cortex hyperplasias and adenomas and corticotropin-independent Cushing's syndrome. Orthologs exist in mouse and rat, both named Prkaca; check the datasheet of any product for its validated reactivity.
Other protein kinase A subunits, AGC family kinases and cAMP signalling pathway targets.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P17612; product specifications from Assay Genie datasheets.